Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy

Introduction: Women after risk-reducing salpingo-oophorectomy (RRSO) can have impaired sexual functioning, but whether there is an association between hormone levels and sexual functioning is unclear. Aim: To determine whether hormone levels are associated with sexual functioning in women after RRSO...

Full description

Bibliographic Details
Main Authors:	Nora Johansen, MD, Astrid H. Liavaag, MD, PhD, Lars Mørkrid, MD, PhD, Trond M. Michelsen, MD, PhD
Format:	Article
Language:	English
Published:	Oxford University Press 2018-06-01
Series:	Sexual Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S205011611830031X

Similar Items

Risk-reducing salpingo-oophorectomy for hereditary ovarian cancer
by: FENG Zheng, WEN Hao
Published: (2022-11-01)

Transvaginal laparoscopic salpingo-oophorectomy: an oncological risk-reducing procedure
by: Kostas Lathouras, et al.
Published: (2020-01-01)

Bone density loss after risk reducing salpingo-oophorectomy
by: Andrews L, et al.
Published: (2012-04-01)

Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy
by: Jihye Kim, et al.
Published: (2024-07-01)

Risk-reducing Salpingo-oophorectomy consults and practices during the COVID-19 pandemic
by: A.E. O'Mara, et al.
Published: (2022-08-01)

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
by: Katsuyuki Konnai, et al.
Published: (2023-02-01)

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
by: Zheng Feng, et al.
Published: (2023-06-01)

Perioperative Outcomes of Postmenopausal Women with Colorectal Cancer Undergoing Prophylactic Salpingo-oophorectomy
by: Eveline M. Schoenmaker, et al.

Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
by: Maria Luisa Gasparri, et al.
Published: (2019-07-01)

Primary Peritoneal Cancer Two Decades after a Bilateral Salpingo-Oophorectomy
by: Melinda Rodowa, et al.
Published: (2019-01-01)

Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
by: Alessandra Inzoli, et al.
Published: (2024-12-01)

21 Hormone replacement therapy utilization over time following risk-reducing salpingo-oophorectomy in premenopausal patients at high risk for ovarian cancer
by: Talayeh Ghezelayagh, et al.
Published: (2023-06-01)

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
by: Hidetaka Nomura, et al.
Published: (2023-01-01)

Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer
by: Diana M Eccles, et al.
Published: (2025-02-01)

Serous Tubal Intraepithelial Carcinoma: An Incidental Finding at the Time of Prophylactic Bilateral Salpingo-Oophorectomy
by: Monique Hiersoux Vaughan, et al.
Published: (2015-01-01)

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
by: P. I. Stanciu, et al.
Published: (2019-05-01)

Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant
by: Yoon-Jung Choi, et al.
Published: (2024-10-01)

Normal Testosterone but Higher Luteinizing Hormone Plasma Levels in Men With Hypersexual Disorder
by: Andreas Chatzittofis, MD, PhD, et al.
Published: (2020-06-01)

Cutaneous Metastasis of Ovarian Tumor after Hysterectomy and Bilateral Salpingo-oophorectomy: A Case Report
by: Hamid Naeem, et al.
Published: (2024-06-01)

Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy
by: Alaina J. Kessler, et al.
Published: (2023-03-01)

Risk-reducing salpingo-oophorectomy among diverse patients with BRCA mutations at an urban public hospital: a mixed methods study
by: Kent Hoskins, et al.
Published: (2024-06-01)

Clinical and Demographic Characteristics of Transgender Individuals with Hysterectomy and Bilateral Salpingo oophorectomy: Experience of a Tertiary Center
by: Kübra Hamzaoğlu Canbolat, et al.
Published: (2024-04-01)

Ipsilateral Interstitial Ectopic Pregnancy in a Patient with Previous Total Salpingo-Oophorectomy: A Case Report
by: Mohammad Reza Sasani, et al.
Published: (2022-07-01)

Which Is the Best Surgical Approach for Female-to-Male Sexual Reassignment? A Systematic Review of Hysterectomy and Salpingo-Oophorectomy Options from the Gynecological Perspective
by: Mattia Dominoni, et al.
Published: (2024-07-01)

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
by: Maria Colomba Comes, et al.
Published: (2023-07-01)

Extreme hypernatremia after a laparoscopic hysterectomy and bilateral salpingo-oophorectomy: a case report and literature review
by: Fei Ding, et al.
Published: (2024-10-01)

Sexual Desire Discrepancy: A Position Statement of the European Society for Sexual Medicine
by: Dewitte Marieke, PhD, et al.
Published: (2020-06-01)

The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in <i>BRCA</i> Mutation Carriers and the Role of Physician-Patient Communication
by: Ana C. Alves-Nogueira, et al.
Published: (2023-02-01)

Treatment of Urethral Intercourse and Impact on Female Sexual Function
by: ML Djordjevic, MD, PhD, et al.
Published: (2022-08-01)

Ureterocolic Fistula Secondary to Diverticulitis of the Sigmoid Colon after Laparoscopic Salpingo-Oophorectomy: A Case Report and Literature Review
by: Hirohumi Yamanaka, et al.
Published: (2019-01-01)

Biochemical Changes During the First Year of Feminizing Hormone Therapy in Transfeminine Individuals
by: Johanne Andersen Hojbjerg, MD, PhD, et al.
Published: (2022-02-01)

A novel antimüllerian gene mutation in a woman with high antral follicle count and extremely low serum antimüllerian hormone levels
by: Laura Melado, M.D., Ph.D., et al.
Published: (2024-06-01)

Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors
by: Corien M. Eeltink, RN, et al.
Published: (2020-09-01)

Sexual Life of Women With Mayer-Rokitansky-Küster-Hauser Syndrome After Laparoscopic Vecchietti Vaginoplasty
by: Zlatko Pastor, MD, PhD, et al.
Published: (2017-06-01)

Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma
by: Karin Johansen, MD, et al.
Published: (2021-09-01)

How Is the Sexual Function of Premenopausal Chinese Women Without Hyperlipidemia?
by: Yali Xiang, MD, PhD, et al.
Published: (2020-03-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
by: Łukasz Pyka MD, PhD, et al.
Published: (2023-12-01)

Gender Differences in the Association Between Sexual Orientation and Risky Sexual Behavior Among College Students With Sexual Experience in Sichuan Province, Chinese
by: Yajie Li, MD, et al.
Published: (2022-10-01)

Safe Sexual Practices in the COVID-19 Pandemic Period
by: Lucia Alves da Silva Lara, MD, PhD, et al.
Published: (2020-12-01)

Safety of transgender hormone therapy
by: Vin Tangpricha, MD, PhD
Published: (2015-12-01)